SCHEMBL19620603

SCHEMBL19620603

NC1=C(OSCc2ccccc2)C(=O)C(c2ccccc2)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
RAB9A P51151 2/20 0.38
SLC6A3 Q01959 1/20 0.38
ADK P55263 4/20 0.37
ALDH1A1 P00352 5/20 0.33
CYP19A1 P11511 1/20 0.33
CA2 P00918 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 1/20 0.32
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 1/20 0.31
HTR2B P41595 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
NPC1 O15118 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620522 0.91 KDM4E (0.42) POLBMAPTKDM4ERAB9AADK
SCHEMBL19620542 0.91 POLB (0.42) POLBMAPTKDM4ERAB9ASLC6A3
SCHEMBL19620533 0.91 MAPT (0.42) POLBMAPTKDM4ERAB9ASLC6A3
SCHEMBL19620675 0.91 MAPT (0.42) POLBMAPTKDM4ERAB9ASLC6A3
SCHEMBL19620650 0.89 CYP19A1 (0.42) POLBMAPTKDM4ERAB9AALDH1A1
SCHEMBL19620500 0.89 ADK (0.40) POLBMAPTKDM4EADKHTT
SCHEMBL19620501 0.89 MAPT (0.41) POLBMAPTKDM4ERAB9AADK
SCHEMBL19620570 0.88 MAPT (0.39) POLBMAPTKDM4ESLC6A3ALDH1A1
SCHEMBL19620507 0.88 KDM4E (0.39) POLBMAPTKDM4EALDH1A1CYP19A1
SCHEMBL22902049 0.88 MAPT (0.39) POLBMAPTKDM4ERAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed